Nantahala Capital Management, LLC / ABEO
Nantahala Capital Management, LLC’s Abeona Therapeutics Inc Position
Does Nantahala Capital Management, LLC own Abeona Therapeutics Inc (ABEO)? Yes — 5.01M shares worth $22M (+0.83% of its 13F portfolio) as of Q1 2026, up from 4.96M shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
5.01M
% of Portfolio
+0.83%
Quarters Held
14
currently held
Position History ABEO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.01M | $22M | +0.83% |
| Q4 2025 | 4.96M | $26M | +0.86% |
| Q3 2025 | 4.56M | $24M | +0.84% |
| Q2 2025 | 4.37M | $25M | +0.97% |
| Q1 2025 | 3.51M | $17M | +0.66% |
| Q4 2024 | 3.53M | $20M | +0.84% |
| Q3 2024 | 3.43M | $22M | +1.10% |
| Q2 2024 | 6.94M | $29M | +0.86% |
| Q1 2024 | 2.31M | $17M | +0.96% |
| Q4 2023 | 4.50M | $23M | +0.67% |
| Q3 2023 | 2.30M | $10M | +0.83% |
| Q2 2023 | 1.40M | $6M | +0.55% |
| Q1 2023 | 1.43M | $4M | +0.31% |
| Q4 2022 | 272.7K | $4M | +0.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nantahala Capital Management, LLC’s full portfolio or all institutional holders of ABEO.